Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 2677 | 361 | 0.5781 | 0.5745 | 0.1349 | 0.1322 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 2 | 1348 | 506 | 0.2102 | 0.2193 | 0.3754 | 0.3870 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 1388 | 504 | 0.2207 | 0.2193 | 0.3631 | 0.3870 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 1378 | 473 | 0.2259 | 0.2248 | 0.3433 | 0.3610 |
WM-115 | Vemurafenib | Dasatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 1340 | 471 | 0.2169 | 0.2248 | 0.3515 | 0.3610 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 4458 | 280 | 1.0429 | 1.0000 | 0.0628 | 0.0644 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 4353 | 298 | 1.0122 | 1.0000 | 0.0685 | 0.0644 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 2653 | 520 | 0.5325 | 0.5321 | 0.1960 | 0.1853 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 2538 | 469 | 0.5165 | 0.5321 | 0.1848 | 0.1853 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 2484 | 484 | 0.4993 | 0.5260 | 0.1948 | 0.1795 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 2626 | 435 | 0.5469 | 0.5260 | 0.1657 | 0.1795 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 2185 | 353 | 0.4573 | 0.4479 | 0.1616 | 0.1688 |
WM-115 | Vemurafenib | Dasatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 2059 | 336 | 0.4301 | 0.4479 | 0.1632 | 0.1688 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 2034 | 549 | 0.3707 | 0.3578 | 0.2699 | 0.2762 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1955 | 588 | 0.3412 | 0.3578 | 0.3008 | 0.2762 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 1983 | 575 | 0.3515 | 0.3661 | 0.2900 | 0.2461 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 1963 | 519 | 0.3605 | 0.3661 | 0.2644 | 0.2461 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1667 | 411 | 0.3135 | 0.3432 | 0.2466 | 0.2379 |
WM-115 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1841 | 377 | 0.3655 | 0.3432 | 0.2048 | 0.2379 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 3197 | 306 | 0.7217 | 0.7092 | 0.0957 | 0.0818 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 3086 | 246 | 0.7089 | 0.7092 | 0.0797 | 0.0818 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1738 | 607 | 0.2823 | 0.2911 | 0.3493 | 0.3460 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1717 | 570 | 0.2863 | 0.2911 | 0.3320 | 0.3460 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 2023 | 423 | 0.3994 | 0.4161 | 0.2091 | 0.2078 |
WM-115 | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 2247 | 458 | 0.4466 | 0.4161 | 0.2038 | 0.2078 |